NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Paragon 28, Inc. (NYSE: FNA) and its board of directors concerning the proposed ...

Shares of FNA opened at $13.03 on Wednesday. Paragon 28 has a 1-year low of $4.65 and a 1-year high of $14.79. The company has a market capitalization of $1.09 billion, a P/E ratio of -17.60 and a ...

Paragon 28 had a negative net margin of 25.31% and a negative return on equity of 37.90%. The firm had revenue of $62.30 million for the quarter, compared to the consensus estimate of $60.58 million.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

During the last three months, 5 analysts shared their evaluations of Paragon 28 FNA, revealing diverse outlooks from bullish to bearish. The table below offers a condensed view of their recent ...

Paragon 28, Inc. FNA shares ended the last trading session 8.3% higher at $12.99. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

Fintel reports that on January 29, 2025, Needham downgraded their outlook for Paragon 28 (NYSE:FNA) from Buy to Hold. Analyst Price Forecast Suggests 12.46% Upside As of January 29, 2025 ...

Bengaluru: Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion to expand its portfolio of orthopedic surgical devices. The deal will give Zimmer ...